TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | 1 | 2 | 1 | -2 | -20 | -4 |
| P | %wins | 100 | 100 | 100 | 100 | 0 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/19 17:30 | 5/13/19 | GNC | Gnc Holdings, Inc. | DE | Retail | Grocer | Food Stores | Lawrence Cameron William | PA | O | SVP Fina | P | 9 | 1.86 | 0 | 5 | 33 | 20 | D | ||||||||||||||
2/24/11 17:04 | 2/22/11 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lawrence Cameron William | A1 | O | Principa | M.d | 6 | 3.00 | 0 | 2 | 53 | 5 | I | 330 | -6 | 19 | -5 | -8 | -1 | -2 | -1 | 1 | -3 | -3 | 19 | -27 | -2 |
11/10/10 12:27 | 11/9/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lawrence Cameron William | A1 | O | Principa | P | 10 | 15.73 | 3 | 1 | 23 | 4 | I | 445 | -48 | -20 | 5 | 12 | -10 | 0 | -1 | 0 | 1 | 2 | 1 | -2 | -20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |